Characteristic | N (%) or Median [IQR] |
---|---|
Age (years) | 62 (48–71) |
Sex (male) | 80 (50.3) |
Hospital unit | |
Medical | 129 (81.1) |
ICU | 19 (11.9) |
ED | 11 (6.9) |
Acquisition | |
CA-CDI | 28 (17.6) |
HO-CDI | 113 (71.1) |
CO-HCFA | 18 (11.3) |
Severity | |
Non-severe | 71 (44.7) |
Severe | 47 (29.6) |
Severe complicated (fulminant) | 41 (25.8) |
Time to CDI from admission, daysa | 7 (2–20) |
Non-CDI antibiotic therapy | 121 (76.1) |
Number of antibioticsb | 3 (1–5) |
Cancer chemotherapy | 22 (13.8) |
Acid suppression therapy | 120 (75.5) |
Type of acid suppression therapyc | |
Proton pump inhibitor | 47 (29.6) |
H2-receptor antagonist | 2 (1.3) |
Antacid | 1 (0.6) |
> 1 type | 70 (44) |
Lower gastrointestinal disease | 14 (8.8) |